# Ophelia **Source:** https://geo.sig.ai/brands/ophelia **Vertical:** Healthcare **Subcategory:** General **Tier:** Challenger **Website:** ophelia.com **Last Updated:** 2026-04-14 ## Summary Telehealth opioid use disorder treatment with buprenorphine prescribing; removing geographic barriers to MAT for patients in 20+ states through online clinical visits. ## Company Overview Ophelia is a telehealth platform specializing in medication-assisted treatment (MAT) for opioid use disorder, providing access to buprenorphine (Suboxone) through online consultations and prescription management for patients across the United States. Founded in 2019 and headquartered in New York City, Ophelia addresses the severe treatment access gap in opioid addiction care — where millions of Americans with opioid use disorder cannot access MAT due to provider shortages, geographic barriers, stigma, or cost. Ophelia's care model is built around online visits with licensed clinicians who can prescribe buprenorphine (following the DEA's removal of the in-person visit requirement for MAT prescriptions during COVID-19 and subsequent legislation making telemedicine prescribing permanent). Patients receive medication at their pharmacy, regular telehealth check-ins with their care team, and behavioral health support through the platform — making evidence-based addiction treatment accessible without requiring specialized in-person clinic visits. In 2025, Ophelia competes in the telehealth addiction treatment market alongside Bicycle Health, Workit Health, Eleanor Health, and traditional outpatient addiction treatment programs increasingly adding telehealth capabilities. The opioid crisis remains a devastating public health emergency — over 80,000 Americans die annually from opioid overdoses — creating immense demand for effective, accessible treatment. Ophelia's 2025 strategy focuses on expanding its state coverage (now available in 20+ states), growing insurance network partnerships to reduce out-of-pocket costs for patients, and demonstrating outcomes data showing its model's effectiveness in maintaining long-term recovery. ## Frequently Asked Questions ### What is Ophelia? Ophelia is a virtual-first telehealth platform founded in 2020 that provides evidence-based treatment for opioid use disorder (OUD). The company offers fully virtual care including medications for opioid use disorder (MOUD) through a telehealth model. ### What services does Ophelia offer? Ophelia provides opioid addiction treatment through telehealth, including buprenorphine prescriptions, MOUD (medications for opioid use disorder) services, and comprehensive virtual addiction care. All services are delivered through their virtual-first platform. ### Who is Ophelia for? Ophelia is designed for individuals seeking treatment for opioid use disorder (OUD). The platform serves patients across 49 states and Washington D.C., including those with Medicaid coverage in participating states. ### When was Ophelia founded? Ophelia was founded in 2020 and participated in Y Combinator's Winter 2020 (W20) batch. ### Where is Ophelia based? Ophelia is headquartered in New York, NY. The company is licensed to provide virtual care in 49 states plus Washington D.C. ### How much funding has Ophelia raised? Ophelia has raised $68 million in total funding, including a $50 million Series B round in December 2021 led by Tiger Global. Other investors include Y Combinator and Menlo Ventures. ### What are Ophelia's key achievements? In 2024, Ophelia became the first fully virtual provider to earn Pennsylvania's Center of Excellence designation. The company is now licensed in 49 states plus D.C. and expanded Medicaid coverage to 3 million New Jersey residents in October 2024. ### What is Ophelia's treatment approach? Ophelia uses a virtual-first telehealth model to deliver evidence-based treatment for opioid use disorder, including MOUD services. Their approach allows patients to receive care, including buprenorphine prescriptions, entirely through virtual appointments. ### How much does Ophelia cost? Ophelia charges $245 per month plus medication costs. The company also accepts Medicaid in participating states, including coverage for 3 million residents in New Jersey as of October 2024. ### What recent developments has Ophelia announced? Recent developments include becoming the first virtual provider to receive Pennsylvania's Center of Excellence designation in 2024 and expanding Medicaid coverage to 3 million New Jersey residents in October 2024. DEA telemedicine flexibilities that support Ophelia's services have been extended through December 2025. ## Tags healthtech, global, b2b --- *Data from geo.sig.ai Brand Intelligence Database. Updated 2026-04-14.*